TAO Synergies TAOX
NASDAQ TAOX
$4.41 +0.02 (+0.46%)
At close: Oct 2, 2026 · 4:00 PM EDT

TAO Synergies (TAOX) Non Operating Investment Income (2025 - 2026)

Updated

TAO Synergies' Non Operating Investment Income was -$8.44 million in Q2 2026, compared with -$14,368 a year earlier.

Analysis

TAO Synergies (TAOX) Non Operating Investment Income (2025 - 2026) Analysis & Trends

For FY2025, Non Operating Investment Income at TAO Synergies came in at -$303,046.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 TAO Synergies 32.96 Mn 32.96 Mn - -8.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8.44 Mn
Mar 31, 2026 350,740.00
Jun 30, 2025 -14,368.00
API Access

TAO Synergies Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=TAOX&period=max&api_key=YOUR_API_KEY